Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Compatibility

Phase 3

Completed

• Conditions: Hygiene
• Interventions: Drug: Dermacyd PH_DETINBACK (Lactic Acid)

• Registration Number: NCT00785681
• Lead Sponsor: Sanofi

Brief Summary

The purpose of this study is to demonstrate the absence of irritation potential (primary dermical irritability and cumulated dermical irritability) and allergy (sensibilization) of the product Dermacyd PHDETINBACK Sweet Flower.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-07
• Primary Completion: 2008-09
• Study Completion: 2008-09
• Study First Submitted: 2008-11-04
• Study First Submitted QC: 2008-11-04
• Study First Posted: 2008-11-05
• Status Verified: 2009-08
• Last Update Submitted: 2009-08-21
• Last Update Posted: 2009-08-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 53

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	Dermacyd PH_DETINBACK (Lactic Acid)	Dermacyd PH_DETINBACK (Lactic Acid)

Primary Outcome Measures

Name	Time	Method
The absence of primary and accumulated dermical irritability and dermical sensitivity will be evaluated using International Contact Dermatitis Research Group (ICDRG) scale.	Throughout the study

Trial Locations

Locations (1)

Sanofi-Aventis Administrative Office; 🇧🇷 Sao Paulo, Brazil